Percutaneous left atrial appendage occlusion discrepancy between randomised trials and clinical practice
In patients with atrial fibrillation and previous episodes of bleeding on oral anticoagulant treatment, left atrial appendage occlusion (LAAO) has emerged as an alternative way to decrease the risk of stroke.The use of the procedure has been on the rise, and the news coverage has been dominated by a...
Main Authors: | Thomas Kümler, Niels Holmark Andersen, Jarl Emanuel Strange |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-10-01
|
Series: | Open Heart |
Online Access: | https://openheart.bmj.com/content/9/2/e002079.full |
Similar Items
-
Percutaneous Left Atrial Appendage Occlusion—Current Evidence and Future Directions
by: Johannes Rotta detto Loria, et al.
Published: (2023-11-01) -
Percutaneous Occlusion of the Left Atrial Appendage with Thrombus Irresponsive to Antithrombotic Therapy
by: Krzysztof Kaczmarek, et al.
Published: (2021-02-01) -
Percutaneous Left Atrial Appendage Occlusion Therapy: Past, Present, and Future
by: Xinqiang Han, et al.
Published: (2023-04-01) -
Effectiveness and Safety of an Outpatient Program for Percutaneous Left Atrial Appendage Occlusion
by: Fabián Blanco-Fernández, et al.
Published: (2023-10-01) -
Percutaneous Left Atrial Appendage Occlusion Therapy: Evolution and Growing Evidence
by: Xinqiang Han, et al.
Published: (2023-07-01)